Tradestie Institutional Equity Comparison Engine

ABCL vs ABSI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABCL Overall Edge

ABCL Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AbCellera Biologics Inc. Common Shares (ABCL) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABSI counters with relative strength in Options & Structure. Fundamentally, ABCL trades at 27.6x Forward P/E with -1550.0% operating margin (-76.3% YoY revenue) versus ABSI at N/M Forward P/E and -9108.3% operating margin (-19.6% YoY). In options structure, ABCL sits in CONSOLIDATION (25th %ile IV; Dealer Gamma Walls on Pro) against ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ABCL
ABCL 27.6x vs ABSI N/M Fwd P/E
Growth & Margin Winner ABCL
Op Margin -1550.0% vs -9108.3% ยท YoY -76.3% vs -19.6%
Momentum & Technical Winner ABCL
1Y +209.0% vs +192.6% ยท 52W Pos 69% vs 53%
Options & Structure Winner ABSI
CONSOLIDATION (25th %ile IV) vs BREAKDOWN (15th %ile IV)
ABCL NASDAQ
AbCellera Biologics Inc. Common Shares
Pharmaceutical Preparations
$11.19
-2.65% 1D
Market Cap $3.8B
1M Return -5.21%
1Y Return +208.98%
Forward P/E 27.6x
Unified AI Score
63.3 / 100 BUY
Tech 57.0 Fund 58.0 Flow 67.0 Mom 54.0
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.72
-8.58% 1D
Market Cap $1.6B
1M Return -6.36%
1Y Return +192.61%
Forward P/E N/M
Unified AI Score
41.2 / 100 SELL
Tech 30.0 Fund 51.0 Flow 71.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABCL +208.98% ABSI +192.61% Spread: +16.37 pp (ABCL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ABCL Revenue ABSI Revenue ABCL Op. Margin ABSI Op. Margin Margin Edge
FY2019 $10M N/A -35.5% N/A ABCL
FY2020 $230M $0M 66.9% -278.3% ABCL
FY2021 $380M $0M 54.5% -1573.4% ABCL
FY2022 $490M $10M 44.6% -1857.5% ABCL
FY2023 $40M $10M -623.8% -2020.2% ABCL
FY2024 $30M $0M -1091.7% -2401.6% ABCL
FY2025 $80M $0M -289.0% -4297.0% ABCL

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABCL (8) vs ABSI (2)
Institutional Metric ABCL ABSI Criterion Row Winner
Market Capitalization Scale $3.8B $1.6B Larger Scale ABCL
Trailing P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Forward P/E Ratio Valuation 27.6x N/M Lower Multiple ABCL
Revenue Growth (YoY) Growth -76.3% -19.6% Higher Growth ABSI
Operating Margin (TTM) Profitability -1550.0% -9108.3% Higher Margin ABCL
Net Profit Margin Profitability -248.8% 0.0% Higher Margin ABSI
Return on Equity (ROE) Capital Efficiency -17.3% -58.6% Higher ROE ABCL
52-Week Range Position Momentum 69% ($3โ€“$15) 53% ($2โ€“$13) Stronger Trend ABCL
Beta / 30D Volatility Risk Regime 2.31ฮฒ ยท 87% Vol 3.31ฮฒ ยท 126% Vol Lower Realized Risk ABCL
Unified Institutional Score Composite Signal 63.3 / 100 (BUY) 41.2 / 100 (SELL) Higher Composite ABCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABCL vs ABSI Buy Guide
ABCL CONSOLIDATION
34d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 25th %ile
IV Regime Compressed (<25th %ile)
Live ABCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABSI BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ABSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABCL nor ABSI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.